Amblyopia Market size was valued at USD 5.2 billion in 2024 and is anticipated to surpass USD 8.8 billion by 2037, registering a CAGR of 4.5% during the forecast timeline i.e. 2025-2037. In 2025, the industry size of amblyopia is evaluated at USD 5.4 billion.
The amblyopia market is driven by the increased exposure to digital screens by children and teenagers which tends to exacerbate underlying vision problems. For instance, in May 2022, according to an article published by Frontiers in Pediatrics, amblyopia was recognized as a common vision disorder among children. The reported incidence of amblyopia was 1–5% worldwide in 2022. In September 2021, according to the National Library of Medicine, amblyopia was the most common cause of monocular visual impairment in children, with a prevalence of 2–3%.
Furthermore, advances in diagnostics have allowed detection and intervention much earlier, where parents and care providers seek to take proactive management of this condition. Moreover, education about the need for regular eye examinations among parents heightened awareness of amblyopia consequences if left undiagnosed. For instance, in February 2022, a survey was conducted by NLM on parents' attitudes toward their children wearing glasses and getting eye surgery when necessary were favorable for 427 (76.9%) and 474 (85.4%) parents, respectively. Of the participants, more than half, which is 58.6% had taken their kids to an ophthalmology clinic for a checkup.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.5% |
|
Base Year Market Size (2024) |
USD 5.2 billion |
|
Forecast Year Market Size (2037) |
USD 8.8 billion |
|
Regional Scope |
|
Treatment (Eye Patches, Atropine drops, Glasses, Video game, Others)
Eye patches segment is predicted to capture amblyopia market share of around 56.8% by the end of 2037, due to their efficacy as a primary treatment modality for promoting visual acuity in the affected eye. Its simplicity and the availability of various designs appeal to seek it as an effective solution. For instance, in December 2024, COSRX announced the release of the peptide collagen hydrogel eye patch for a variety of under-eye issues. With the help of a potent blend of four multipurpose peptides, these hydrogel patches improve skin elasticity, reduce fine lines, and brighten the area beneath the eyes, providing a complete solution for revitalizing the sensitive skin surrounding the eyes. Hence, the eye patches segment continues to hold a significant share underscoring its foundational role in amblyopia management strategies.
End user (Hospitals & Pharmacies, Ophthalmic Clinics)
The hospitals & pharmacies segment is anticipated to dominate the amblyopia market by 2037. This growth is attributable primarily due to the critical role played by these units in providing the comprehensive eye care services and the availability of treatments for patients. Hospitals are the main centers for diagnosis and management as they are provided with specialized ophthalmology departments that offer sophisticated diagnostic tools and therapeutic interventions. For instance, in June 2023, Eye-Q announced that it had installed a customized and state-of-the-art LASIK machine at its eye care facility in Rewari, India. This device revolutionized laser vision correction and provided patients with cutting-edge care.
Our in-depth analysis of the global market includes the following segments:
|
Treatment |
|
|
Type |
|
|
Diagnosis |
|
|
End user |
|
Asia Pacific Market Statistics
Asia Pacific amblyopia market is set to hold revenue share of over 42% by the end of 2037. The integration of innovative therapeutic approaches such as virtual reality-based treatments and improved occlusion therapies has expanded the appeal of amblyopia management strategies, thereby driving demand among both practitioners and patients. Thus, these trends underscore a significant shift towards prioritizing early diagnosis and effective treatment modalities for amblyopia within the healthcare landscape.
India amblyopia market is expected to grow substantially during the projected period. This growth is attributable to the expanding portfolios of manufacturers to diversify their range of delivering efficient patient outcomes through innovating their product lines. For instance, in July 2023, with the introduction of an extensive line of high-quality, reasonably priced eye care products, Alkem Laboratories declared its foray into the ophthalmology industry. This move demonstrates that Indian patients can now obtain high-quality eye care products at reasonable costs.
China amblyopia market is fostering rapidly owing to the growing portion of eye dryness incidences in the country. For instance, according to National Institutes of Health stated that, the dry eye symptoms evaluated in a questionnaire occurred in about 21% of the adult population in China. Thus, the country is making efforts to improve the situation prevailing. For instance, it was announced in December 2022, that in the first quarter of 2025, China Pharma Holdings (CPHI) plans to introduce a Dry Eye Disease Therapeutic Device. This medical device is protected by a patent and is used to treat dry eye diseases.
North America Market Analysis
The amblyopia market in North America is gaining traction and is expected to witness lucrative growth during the forecast timeline i.e. 2025-2037. There is a high surge in the prevalence of visionary disorders incidences in the region. For instance, in March 2023, according to the Oxford Academic reports of 2018, an estimated 7.08 million Americans, including 1.62 million under 40, suffer from eye and vision disorders. Thus, it is expected to flourish in developing and improvising effective tools to correct defects in the eyes.
The U.S. amblyopia market is growing rapidly due to expanding population. This explosion predominantly composed of children with having high density of visionary defects. For instance, in June 2022, about 3% of children in the U.S. by the age of three suffer from strabismus and amblyopia, according to an article in Investigative Ophthalmology and Visual Science. Hence, the country is making significant efforts in revamping its reach through optimal healthcare facilities to its population.
Canada amblyopia market is witnessing great surge due to continuous developments and innovations in the eye care products. Various manufacturers are deploying their efforts to deliver efficacy in meeting the trending and changing consumer demands. For instance, in June 2023, Bausch + Lomb Corporation introduced INFUSE Multifocal silicone hydrogel (SiHy) daily disposable contact lenses. These brand-new daily disposable lenses provide patients with comfortable, dry eyes.
The development of healthcare infrastructure and growing technological advancements by businesses in the amblyopia market are expected to greatly offset the obstacles and promote market expansion in the years to come. For instance, in October 2021, Luminopia announced that Luminopia One, received de novo premarket approval from the U.S. Food and Drug Administration (FDA). This aimed at improving visual acuity in children with amblyopia disease.
Here's the list of some key players:
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?